Enliven Therapeutics ELVN Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Enliven Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Enliven Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Enliven Therapeutics's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Enliven Therapeutics's common stock?
- Enliven Therapeutics (ELVN) reported common stock of $61K in Q1 2026.
- How has Enliven Therapeutics's common stock changed year-over-year?
- Enliven Therapeutics's common stock increased by 24.5% year-over-year, from $49K to $61K.
- What is the long-term trend for Enliven Therapeutics's common stock?
- Over 5 years (2020 to 2025), Enliven Therapeutics's common stock has grown at a 26.8% compound annual growth rate (CAGR), from $18K to $59K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).